United Pompe Foundation
  • Home
  • About
  • Clinical Trial Process
  • Donations
  • Events
  • Resources
    • EP Magazine Article
    • Videos
    • Related Articles
    • Pompe Links
  • Contact Us
Select Page

Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease

by United Pompe | Dec 8, 2016 | News

December 8, 2016 Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease ATB200/AT2221 Safety Data Show No Infusion-Associated Reactions Following 100+ Infusions Clinical Pharmacokinetic (PK) Profile...

Recent Posts

  • A Primer for Family Medicine and Primary Care: Focusing on Pompe Disease
  • POMPE Survey
  • Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease
  • CLINICAL TRIALS/STUDIES
  • Higher Lumizyme Dose May Help Prevent Pompe Progression in Infants, Case Report Suggests

Archives

  • September 2019
  • March 2019
  • September 2018
  • August 2018
  • July 2018
  • March 2017
  • December 2016
  • November 2016
  • July 2016
  • January 2016
  • October 2014

About

The United Pompe Foundation was formed to assist patients and/or their families with medical costs and other expenses that these patients and families face and may not be able to cover, or fully cover, through their insurance.

Contact

United Pompe Foundation
5100 N. Sixth Street #119
Fresno, CA 93710

Email: [email protected]
Phone: (559) 227-1898
Fax: (559) 227-1898

Copyright © 2018 United Pompe Foundation | All Rights Reserved | WUR